|
US6752987B1
(en)
|
1995-02-28 |
2004-06-22 |
The Regents Of The University Of California |
Adenovirus encoding human adenylylcyclase (AC) VI
|
|
US6306830B1
(en)
|
1996-09-05 |
2001-10-23 |
The Regents Of The University Of California |
Gene therapy for congestive heart failure
|
|
US7745416B2
(en)
*
|
1995-04-11 |
2010-06-29 |
The Regents Of The University Of California |
Method for in vivo regulation of cardiac muscle contractility
|
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
|
US20030206891A1
(en)
*
|
1995-06-07 |
2003-11-06 |
Ariad Gene Therapeutics, Inc. |
Rapamycin-based biological regulation
|
|
ATE452981T1
(de)
*
|
1995-06-07 |
2010-01-15 |
Univ North Carolina |
Die transduktion von myoblasten mittels vektoren aus adenoassoziierten viren
|
|
US5858351A
(en)
*
|
1996-01-18 |
1999-01-12 |
Avigen, Inc. |
Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
|
|
US5962313A
(en)
*
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
US5846528A
(en)
*
|
1996-01-18 |
1998-12-08 |
Avigen, Inc. |
Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
|
|
JP2002514899A
(ja)
*
|
1996-03-04 |
2002-05-21 |
ターゲティッド ジェネティックス コーポレイション |
組換えａａｖベクターを用いて血管中の細胞を形質導入するための方法
|
|
US20020037867A1
(en)
*
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
JP2001500497A
(ja)
*
|
1996-09-06 |
2001-01-16 |
トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスに指図される遺伝子治療の方法
|
|
US6486133B1
(en)
|
1997-03-07 |
2002-11-26 |
The Wistar Institute Of Anatomy And Biology |
Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
|
|
US6989264B2
(en)
*
|
1997-09-05 |
2006-01-24 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
US6953690B1
(en)
|
1998-03-20 |
2005-10-11 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
US6129757A
(en)
*
|
1998-05-18 |
2000-10-10 |
Scimed Life Systems |
Implantable members for receiving therapeutically useful compositions
|
|
EP1139751A4
(en)
*
|
1998-12-28 |
2003-03-19 |
Arch Dev Corp |
EFFICIENT AND STABLE -I (IN VIVO) GENE TRANSFER TO CARDIOMYCETS USING RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS
|
|
US7078387B1
(en)
|
1998-12-28 |
2006-07-18 |
Arch Development Corp. |
Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
|
|
JP4693244B2
(ja)
|
1999-03-18 |
2011-06-01 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
|
|
EP1255822A2
(en)
|
1999-12-27 |
2002-11-13 |
The Regents Of The University Of California |
Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
|
|
AU2001260214A1
(en)
*
|
2000-04-13 |
2001-10-30 |
D. Collen Research Foudation Vzw |
Use of inhibition of a gas6 function or of a gas6 receptor for preventing and treating a cardiovascular disease
|
|
DE60129229T2
(de)
*
|
2000-08-17 |
2008-05-08 |
Ozawa, Keiya |
Adeno-assoziierte virus-vermittelte übertragung von angiogenesefaktoren
|
|
EP1870473A1
(en)
*
|
2000-08-17 |
2007-12-26 |
Keiya Ozawa |
Adeno-associated virus-mediated delivery of angiogenic factors
|
|
US20030064025A1
(en)
*
|
2001-04-05 |
2003-04-03 |
Xiaoming Yang |
Imaging systems for in vivo protocols
|
|
US20020192688A1
(en)
*
|
2001-04-05 |
2002-12-19 |
Xiaoming Yang |
Imaging nucleic acid delivery
|
|
AU2002331669A1
(en)
|
2001-08-23 |
2003-03-10 |
The Wistar Institute Of Anatomy And Biology |
An organotypic intestinal culture and methods of use thereof
|
|
AU2003228410A1
(en)
*
|
2002-04-01 |
2003-10-20 |
The Johns Hopkins University School Of Medicine |
Device, systems and methods for heating of a vessel in combination with mr/nmr imaging
|
|
US20040009151A1
(en)
*
|
2002-04-04 |
2004-01-15 |
Kay Mark A. |
Methods for delivering recombinant adeno-associated virus virions to the liver of a mammal
|
|
EP1486567A1
(en)
*
|
2003-06-11 |
2004-12-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Improved adeno-associated virus (AAV) vector for gene therapy
|
|
WO2005027995A2
(en)
*
|
2003-09-19 |
2005-03-31 |
The Trustees Of The University Of Pennsylvania |
Global myocardial perfusion catheter
|
|
US20050244377A1
(en)
*
|
2003-12-24 |
2005-11-03 |
Daniel Sigg |
Methods of treating cardiac disorders by suppressing the expression of the potassium inwardly-rectifying channel
|
|
US8859273B2
(en)
*
|
2003-12-24 |
2014-10-14 |
Medtronic, Inc. |
Methods of using HCN genes to treat cardiac arrhythmias
|
|
US20060128647A1
(en)
*
|
2003-12-24 |
2006-06-15 |
Daniel Sigg |
Novel oligonucleotides and treating cardiac disorders by using the same
|
|
EP1755400A2
(en)
*
|
2004-06-18 |
2007-02-28 |
The University Of Montana |
Aav mediated gene delivery to cochlear cells
|
|
CN1286981C
(zh)
*
|
2004-11-30 |
2006-11-29 |
华中科技大学同济医学院附属同济医院 |
表达人类cyp2j2反义基因的重组腺相关病毒及其制备方法
|
|
GB2437893A
(en)
*
|
2006-07-25 |
2007-11-07 |
Celladon Corp |
Extended antegrade epicardial coronary infusion of adeno-associated viral vectors for gene therapy
|
|
WO2009105135A1
(en)
|
2008-02-19 |
2009-08-27 |
Celladon Corporation |
Compositions for enhanced uptake of viral vectors in the myocardium
|
|
US9644205B2
(en)
|
2012-04-25 |
2017-05-09 |
The Regents Of The University Of California |
Synthetic promoter for modulating gene expression
|
|
WO2016133917A1
(en)
|
2015-02-16 |
2016-08-25 |
University Of Florida Research Foundation |
Raav vector compositions, methods for targeting vascular endothelial cells and use in treatment of type i diabetes
|
|
PT3405215T
(pt)
*
|
2016-01-19 |
2022-09-20 |
Univ California |
Métodos para o tratamento da doença de danon e outros transtornos da autofagia
|
|
US12460226B2
(en)
|
2018-04-16 |
2025-11-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for treating duchenne muscular dystrophy
|